These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
223 related articles for article (PubMed ID: 21602882)
1. HIPK2 phosphorylates ΔNp63α and promotes its degradation in response to DNA damage. Lazzari C; Prodosmo A; Siepi F; Rinaldo C; Galli F; Gentileschi M; Bartolazzi A; Costanzo A; Sacchi A; Guerrini L; Soddu S Oncogene; 2011 Dec; 30(48):4802-13. PubMed ID: 21602882 [TBL] [Abstract][Full Text] [Related]
2. HIPK2 contributes to PCAF-mediated p53 acetylation and selective transactivation of p21Waf1 after nonapoptotic DNA damage. Di Stefano V; Soddu S; Sacchi A; D'Orazi G Oncogene; 2005 Aug; 24(35):5431-42. PubMed ID: 15897882 [TBL] [Abstract][Full Text] [Related]
3. Overexpression of HIPK2 circumvents the blockade of apoptosis in chemoresistant ovarian cancer cells. Puca R; Nardinocchi L; Pistritto G; D'Orazi G Gynecol Oncol; 2008 Jun; 109(3):403-10. PubMed ID: 18395248 [TBL] [Abstract][Full Text] [Related]
4. Homeodomain-interacting protein kinase 2 is the ionizing radiation-activated p53 serine 46 kinase and is regulated by ATM. Dauth I; Krüger J; Hofmann TG Cancer Res; 2007 Mar; 67(5):2274-9. PubMed ID: 17332358 [TBL] [Abstract][Full Text] [Related]
5. HIPK2 inhibits both MDM2 gene and protein by, respectively, p53-dependent and independent regulations. Di Stefano V; Mattiussi M; Sacchi A; D'Orazi G FEBS Lett; 2005 Oct; 579(25):5473-80. PubMed ID: 16212962 [TBL] [Abstract][Full Text] [Related]
6. Regulation of p53 activity by HIPK2: molecular mechanisms and therapeutical implications in human cancer cells. Puca R; Nardinocchi L; Givol D; D'Orazi G Oncogene; 2010 Aug; 29(31):4378-87. PubMed ID: 20514025 [TBL] [Abstract][Full Text] [Related]
7. Axin stimulates p53 functions by activation of HIPK2 kinase through multimeric complex formation. Rui Y; Xu Z; Lin S; Li Q; Rui H; Luo W; Zhou HM; Cheung PY; Wu Z; Ye Z; Li P; Han J; Lin SC EMBO J; 2004 Nov; 23(23):4583-94. PubMed ID: 15526030 [TBL] [Abstract][Full Text] [Related]
8. Negative regulation of beta4 integrin transcription by homeodomain-interacting protein kinase 2 and p53 impairs tumor progression. Bon G; Di Carlo SE; Folgiero V; Avetrani P; Lazzari C; D'Orazi G; Brizzi MF; Sacchi A; Soddu S; Blandino G; Mottolese M; Falcioni R Cancer Res; 2009 Jul; 69(14):5978-86. PubMed ID: 19567674 [TBL] [Abstract][Full Text] [Related]
10. Homeodomain-interacting protein kinase2 in human idiopathic pulmonary fibrosis. Ricci A; Cherubini E; Ulivieri A; Lavra L; Sciacchitano S; Scozzi D; Mancini R; Ciliberto G; Bartolazzi A; Bruno P; Graziano P; Mariotta S J Cell Physiol; 2013 Jan; 228(1):235-41. PubMed ID: 22689412 [TBL] [Abstract][Full Text] [Related]
11. MDM2-regulated degradation of HIPK2 prevents p53Ser46 phosphorylation and DNA damage-induced apoptosis. Rinaldo C; Prodosmo A; Mancini F; Iacovelli S; Sacchi A; Moretti F; Soddu S Mol Cell; 2007 Mar; 25(5):739-50. PubMed ID: 17349959 [TBL] [Abstract][Full Text] [Related]
12. MYCN sensitizes human neuroblastoma to apoptosis by HIPK2 activation through a DNA damage response. Petroni M; Veschi V; Prodosmo A; Rinaldo C; Massimi I; Carbonari M; Dominici C; McDowell HP; Rinaldi C; Screpanti I; Frati L; Bartolazzi A; Gulino A; Soddu S; Giannini G Mol Cancer Res; 2011 Jan; 9(1):67-77. PubMed ID: 21173028 [TBL] [Abstract][Full Text] [Related]
13. The human protein kinase HIPK2 phosphorylates and downregulates the methyl-binding transcription factor ZBTB4. Yamada D; Pérez-Torrado R; Filion G; Caly M; Jammart B; Devignot V; Sasai N; Ravassard P; Mallet J; Sastre-Garau X; Schmitz ML; Defossez PA Oncogene; 2009 Jul; 28(27):2535-44. PubMed ID: 19448668 [TBL] [Abstract][Full Text] [Related]
14. Hyperglycemia triggers HIPK2 protein degradation. Baldari S; Garufi A; Granato M; Cuomo L; Pistritto G; Cirone M; D'Orazi G Oncotarget; 2017 Jan; 8(1):1190-1203. PubMed ID: 27901482 [TBL] [Abstract][Full Text] [Related]
15. The Tyrosine Kinase c-Abl Promotes Homeodomain-interacting Protein Kinase 2 (HIPK2) Accumulation and Activation in Response to DNA Damage. Reuven N; Adler J; Porat Z; Polonio-Vallon T; Hofmann TG; Shaul Y J Biol Chem; 2015 Jul; 290(27):16478-88. PubMed ID: 25944899 [TBL] [Abstract][Full Text] [Related]
16. Interplay between Mdm2 and HIPK2 in the DNA damage response. Zhang XP; Liu F; Wang W J R Soc Interface; 2014 Jul; 11(96):. PubMed ID: 24829283 [TBL] [Abstract][Full Text] [Related]
17. Homeodomain-interacting protein kinase-2 activity and p53 phosphorylation are critical events for cisplatin-mediated apoptosis. Di Stefano V; Rinaldo C; Sacchi A; Soddu S; D'Orazi G Exp Cell Res; 2004 Feb; 293(2):311-20. PubMed ID: 14729469 [TBL] [Abstract][Full Text] [Related]